PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update

27 Sep 2010 07:00

RNS Number : 3114T
Ashley House PLC
27 September 2010
 



 

 

 

 

Business Update

Dividend update

 

The Board of Ashley House plc, the primary care infrastructure specialist, has decided ahead of its AGM today that it is prudent to withdraw the resolution to approve the final dividend payment due on 29 October. However, the Company intends to declare and pay a special interim dividend at the earliest opportunity.

 

This decision is the result of the lack of conclusion on a second bid approach in recent months for the company's property partner AH Medical Properties plc (AHMP). Release of fees and confirmation of available funding for the construction of four schemes which AHMP has an option to purchase under the Asset Management Agreement had been expected by the end of October. Together with current cash of £800k this would have increased the Company's cash balances to a level more than sufficient to cover the dividend requirement of £1.7m. The Board hopes that the AHMP bid situation will be resolved shortly and is confident that new funding arrangements for Ashley House schemes will be in place soon; however with no certainty on payment dates it would be imprudent to commit to a dividend payment date at this point in time.

 

The Board will provide an update on the special dividend payment as soon as it is able to do so.

 

Scheme progress

 

The Company is pleased to announce that 2 LIFT schemes with a Design and Build value of c. £8m in East London have achieved financial close. These schemes in Tower Hamlets and Hackney have been much delayed but their move to close is reassuring in the light of the current public sector spending environment.

 

Including these 2 schemes, the Company now has 9 schemes in the construction phase with a design and build value of just over £30m. This is the highest value in on site schemes the Company has ever recorded with a significant number of further projects set to move into the construction phase in the second half.

 

 

Outlook

 

The Company's operational performance this year is expected to be in line with management's expectations, based on the levels of current activity and the pipeline of schemes set to move to site in the second half of the year.

 

The White Paper, Equity and Excellence: Liberating the NHS, published on 12 July was more radical than expected in transferring healthcare commissioning to GPs and announcing the abolition of PCTs by 2013. Whilst this may well be of long term benefit to Ashley House given our strength in the GP market, it will inevitably mean the current slow pace in approving schemes continues. There was no reference in the White Paper to healthcare estates or to LIFT, where the company has a leading presence. We continue to monitor the debate in Government on how to make best use of the healthcare estate and are contributing wherever possible.

 

In the light of the White Paper the Company is currently analysing the potential impact on its Public sector partners and assessing any possible consequences for the carrying values of its relevant assets.

 

Jonathan Holmes, CEO commented: 'Despite the challenges arising from the changing healthcare landscape and from uncertainties surrounding the future ownership of our property partner AH Medical Properties affecting our short term ability to fund new schemes, we are delivering positive operational performance and remain confident about the long term prospects of the sector and our business'.

 

ENDS

 

Enquiries:

Ashley House plc

Jonathan Holmes, Chief Executive

Tony Walters, Finance Director

 

Tel: 01628 600340

Numis Securities

(NOMAD and broker to Ashley House) 

Oliver Cardigan/ Simon Blank/ David Poutney

 

Tel: 020 7260 1000

Citigate Dewe Rogerson

Sarah Gestetner/ Ged Brumby

Tel: 020 7638 9571

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSONRROAKUAR
Date   Source Headline
19th Jan 20057:00 amRNSSuspension of shares
19th Jan 20057:00 amRNSSuspension - Ashdene Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.